In the first issue of each month The Pharmaceutical Journal updates the guidance on the legal status of medicines published in the 23rd edition of ‘Medicines, ethics and practice: A guide for pharmacists', which was published in January. The amendments are given in bold type on the first occasion they are printed in the list; thereafter they are repeated each month in light type. The legal status of a product can be obtained by consulting first the latest list of amendments and then the guide. The abbreviations used in the list are those used in the guide and explained in the key to annotations in the body of the guide (pp21 and 61).
| Actal pastils PO |
| Aromasin tablets POM |
| Artelac eye-drops P |
| Cardicor tablets POM |
| Charcodote suspension P |
| Clivarine injection POM |
| Felicium capsules POM |
| Femoston-conti tablets POM |
| Levonelle-2 tablets POM |
| Lysovir capsules POM |
| Micardis tablets POM |
| Norditropin Simplex POM |
| Normosang infusion POM |
| Oxycontin tablets CD POM (amended entry) |
| Oxynorm preparations CD POM (amended entry) |
| Pralenal tablets POM |
| Remicade infusion POM |
| Sonata capsules POM |
| Tobi nebuliser solution POM |
| Tixycolds cold and allergy nasal drops GSL |
| Tixycolds cold and hayfever inhalant capsules GSL |
| Tixycolds syrup P |
| Tixylix baby syrup GSL |